The last OM trial took 2 years... Now Leo wants 2 trials (US/Europe)? There's no chance a trial starts in 2019, so the earliest the phantom trials complete will be 2021 or later... Best scenario is a sale and let someone else move science along with more experience and better finances. Leo's playing games with the partner gossip.
150-200 patients, 2 or 3 sites, easy 25-35 million or more. Chemo/rad effects can mess up patient compliance (and life expectancy, both ways) need the larger sample. I forget how many patients/sites were to be in the 30 million P-3 for ABSSSI that was scrapped. Not sure if we ever saw estimates.
News 
Market Data 
Discover 
